Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs

NCT02347345 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

Sponsor

Rockefeller University

Collaborators

[object Object]